New York State Common Retirement Fund’s VistaGen Therapeutics VTGN Stock Holding History

New York State Common Retirement Fund’s Portfolio VTGN Stock Details VTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-59	Closed	-$110	–	3379
2023 Q2	$110	Sell	59 -4,403	-99%	-$15.4K	﹤0.01%	3420
2023 Q1	$16.7K	Hold	4,462	–	–	﹤0.01%	3146
2022 Q4	$13.8K	Hold	4,462	–	–	﹤0.01%	3202
2022 Q3	$20K	Sell	4,462 -7,093	-61%	-$70.3K	﹤0.01%	3222
2022 Q2	$305K	Sell	11,555 -680	-6%	-$24K	﹤0.01%	2594
2022 Q1	$455K	Hold	12,235	–	–	﹤0.01%	2444
2021 Q4	$716K	Buy	12,235 +7,763	+174%	+$505K	﹤0.01%	2248
2021 Q3	$368K	Sell	4,472 -991	-18%	-$86.1K	﹤0.01%	2631
2021 Q2	$516K	Buy	+5,463	New	+$405K	﹤0.01%	2577

Other funds holding VTGN

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

New York State Common Retirement Fund's VTGN Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of VistaGen Therapeutics (VTGN) in Q3 2023, closing a stake of 59 shares — an estimated $110 sold.

New York State Common Retirement Fund first reported a position in VTGN in Q2 2021 and held it in 9 quarters. The position peaked at $716K in Q4 2021. 34 funds tracked by Wall St. Rank hold VTGN as of Q3 2023.

New York State Common Retirement Fund reported no remaining VistaGen Therapeutics position as of Q3 2023 after selling out during the quarter.
New York State Common Retirement Fund sold 59 VistaGen Therapeutics shares in Q3 2023, an estimated $110.
New York State Common Retirement Fund first reported a position in VistaGen Therapeutics in Q2 2021 and held it in 9 quarters.
New York State Common Retirement Fund's VistaGen Therapeutics position peaked at $716K in Q4 2021.
34 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.